In Vivo Efficacy of the Ketolide ABT-773 (Cethromycin) against Enterococci in a Mouse Peritonitis Model

Using six Enterococcus faecalis and five Enterococcus faecium strains, the ketolide ABT-773 (ABT), now known as cethromycin, was found to have in vivo efficacy against both erythromycin (ERY)-susceptible (Ery(s)) and -intermediate (Ery(i)) enterococci (ABT 50% protective doses [PD(50)s], 0.5 to 4.1...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Pai, Suresh R., Singh, Kavindra V., Murray, Barbara E.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166088/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12878548/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.8.2706-2709.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!